SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
75 hedge funds and large institutions have $112M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
29% more funds holding
Funds holding: 58 → 75 (+17)
24% less capital invested
Capital invested by funds: $147M → $112M (-$34.9M)
Holders
75
Holding in Top 10
2
Calls
$162K
Puts
$3K
Top Buyers
| 1 | +$2.29M | |
| 2 | +$2.17M | |
| 3 | +$1.52M | |
| 4 |
Millennium Management
New York
|
+$1.4M |
| 5 |
Goldman Sachs
New York
|
+$1.11M |
Top Sellers
| 1 | -$6.17M | |
| 2 | -$662K | |
| 3 | -$654K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$423K |
| 5 |
6CM
683 Capital Management
New York
|
-$284K |